Cluster-level dynamic treatment regimens can be used to guide sequential treatment decision-making at the cluster level in order to improve outcomes at the individual or patient-level. In a cluster-level dynamic treatment regimen, the treatment is potentially adapted and re-adapted over time based on changes in the cluster that could be impacted by prior intervention, including aggregate measures of the individuals or patients that compose it. Cluster-randomized sequential multiple assignment randomized trials can be used to answer multiple open questions preventing scientists from developing high-quality cluster-level dynamic treatment regimens. In a cluster-randomized sequential multiple assignment randomized trial, sequential randomizations occur at the cluster level and outcomes are observed at the individual level. This manuscript makes two contributions to the design and analysis of cluster-randomized sequential multiple assignment randomized trials. First, a weighted least squares regression approach is proposed for comparing the mean of a patient-level outcome between the cluster-level dynamic treatment regimens embedded in a sequential multiple assignment randomized trial. The regression approach facilitates the use of baseline covariates which is often critical in the analysis of cluster-level trials. Second, sample size calculators are derived for two common clusterrandomized sequential multiple assignment randomized trial designs for use when the primary aim is a betweendynamic treatment regimen comparison of the mean of a continuous patient-level outcome. The methods are motivated by the Adaptive Implementation of Effective Programs Trial which is, to our knowledge, the first-ever cluster-randomized sequential multiple assignment randomized trial in psychiatry.
Introduction
Interventions aimed at improving individual-level outcomes often occur at a cluster level. [1] [2] [3] Often, it may be necessary to use a tailored and dynamic approach to intervention in order to address cluster-level heterogeneity. 4 For example, due to differences in size, geography, or culture, some clusters may require more intensive or longerduration intervention in order to improve patient-level outcomes.
Cluster-level dynamic treatment regimens (DTRs), also known as adaptive interventions, can be used to guide such sequential intervention decision-making at the cluster level. In a cluster-level DTR, the cluster-level intervention is potentially adapted (or re-adapted) over time based on changes in the cluster that could be ADEPT, which is currently in the field, involves community-based mental health clinics (approximately N ¼ 60) that have failed to respond to an initial six months of REP (pre-randomization). During these six months, each clinic i ¼ 1, . . . , N is expected to identify approximately m i ¼ 10 to 25 patients with mood disorders, all of which are followed for patient-level outcomes throughout the study. Clinics that enter the study (i.e. did not respond to REP at month 6) are randomized with equal probability to receive additional REP þ EF or REP þ EF þ IF. After another 6 months, (i) REP þ EF sites that are still non-responsive are randomized with equal probability to either continue REP þ EF or augment with IF (REP þ EF þ IF) for an additional 12 months, (ii) REP þ EF þ IF sites that are still non-responsive continue REP þ EF þ IF, and (iii) facilitation interventions are discontinued for all sites that are responsive. A clinic is identified as ''not responding'' at months 6 and 12 if 5 50 % of the patients identified to be part of Life Goals during months 0-6 have received !3 Life Goals sessions.
By design, ADEPT has three DTRs embedded within it, which are displayed in Table 1 . Each embedded DTR is labeled (a 1 , a 2 ). For example, DTR ð1, À 1Þ offers REP þ EF at month 6, then REP þ EF is augmented with IF for clinics that remain non-responsive at month 12, whereas EF is discontinued for clinics who are responsive at month 12.
The prototypical SMART design
In ADEPT, only clinics not responding to REP þ EF were re-randomized at the next stage. This type of SMART (but with individual-level randomizations) has been previously employed in autism research, see Kasari et al. 20 and Almirall et al. 21 Figure 1. Schematic of ADEPT. The encircled R signifies randomization; cluster-level randomizations occurred at baseline and after six months of REP þ EF or REP þ EF þ IF following identification of clinic responder status. 
IPW: inverse probability weights.
Many other types of SMART designs are possible (see Methodology Center 10 for a comprehensive list with individual-level randomizations), including SMARTs where all units are subsequently re-randomized to the same set of next-stage intervention options (e.g. Chronis-Tuscano et al. 22 ) and others where all units are re-randomized, but to different next-stage intervention options depending on response/non-response to first-stage intervention (e.g. Lu et al. 23 ). Ultimately, the decision to choose a particular type of SMART is driven by scientific considerations.
By far the most common type of SMART is a two-stage design where (i) all units are randomized to two firststage treatment options, (ii) a subset of units at the end of stage 1 (e.g. non-responders) are re-randomized to second-stage intervention options regardless of choice of first-stage intervention, and (iii) the remaining subset of units (e.g. responders) are not re-randomized. See Figure 2 for a generic example. We call this a ''prototypical SMART design'' given its popularity. Note that in the case of the prototypical SMART, there are four embedded DTRs, see Table 2 .
Published examples of the prototypical SMART (with individual-level randomizations) include Pelham et al. 24 in attention-deficit/hyperactivity disorder, Gunlicks-Stoessel et al. 25 in adolescent depression, August et al. 26 in conduct disorder prevention, Sherwood et al. 27 and Naar-King et al. 28 in weight loss, and McKay et al. 29 in cocaine/alcohol use.
Common primary aims in a SMART
This manuscript develops methods for comparing the mean of a continuous individual-level outcome between the DTRs embedded in a cluster-randomized SMART. This comparison can be conceptualized in various ways as a primary aim. 14, 30 (i) To compare first stage intervention options (averaging over the second stage intervention). In ADEPT, this is a comparison of DTR (À1,.) and the DTRs {(1,1), (1,À1)} (this was the primary aim in ADEPT, see Kilbourne et al. 11 ).
(ii) To compare second stage intervention options (averaging over the first stage intervention). For example, in the prototypical design, this would be a comparison of DTRs {(1,1), (À1,1)} and DTRs {(1,À1), (À1,À1)} (e.g. see aim 3 in Pelham et al. 24 ). (iii) To compare the mean outcome between two DTRs beginning with the same first-stage treatment. In ADEPT, this is a comparison of DTR (1,1) and (1,À1). (iv) To compare the mean outcome between two DTRs that begin with different first stage treatments. In ADEPT, this is a comparison of (1,1) and (À1,.) or of (1,À1) and (À1,.).
The next section develops a regression estimator that can be used to address all of these primary aims using data from a cluster-randomized SMART. Following that, we derive sample size formulae for aim (iv). Simple extensions of standard sample size formulae may be used for primary aims (i), (ii), and (iii).
Methodology 3.1 Marginal mean model
For each SMART participant j ¼ 1, . . . , m i within each site i ¼ 1, . . . , N, we envision a primary end-of-study individual-level outcome Y ij . Let the p Â 1 vector X ij denote a pre-specified set of baseline covariates measured prior to the initial randomization. The baseline covariates, X ij , may be patient-level (e.g. age) or cluster-level (e.g. clinic location).
Denote E a 1 ,a 2 ðY ij jX ij Þ as the marginal mean of Y ij had the entire population been assigned to the DTR (a 1 , a 2 ), conditional on baseline covariates, X ij . 31, 32 The mean, E a 1 ,a 2 ðY ij jX ij Þ, averages over the response/non-response measure used in the DTR (a 1 , a 2 ).
Let ðX ij , a 1 , a 2 ; b, gÞ denote a marginal structural model 13, [33] [34] [35] [36] for the mean E a 1 ,a 2 ðY ij jX ij Þ, which is linear in the unknown parameters ðb, gÞ. We provide examples below. We denote the causal effects between the DTRs by the q Â 1 vector b, and denote associational effects between X ij and Y ij by the p Â 1 vector g.
Example 1: ADEPT
An example marginal mean model for the ADEPT study is
where I a 1 ¼1 is an indicator function which equals 1 when a 1 ¼ 1.
Here we use a vector b with q ¼ 3 to capture the causal effects for the three embedded DTRs. The covariates, X ij , could include, for example, the three baseline site-level variables used to stratify the initial randomization: US state (Colorado or Michigan), whether the site was a primary care or mental health site, and a site-average of individual MH-QOL scores. Using this model to address a primary aim of type (iv) above, the difference between the mean outcome had all clusters received DTR (1,1) and the mean outcome had all clusters received DTR (À1,.)-i.e. E 1,1 ðY ij Þ À E À1,: ðY ij Þ-is given by 2 1 þ 2 .
Example 2: Prototypical SMART
In the prototypical SMART, we use a vector b with q ¼ 4 to capture the causal effects for the 4 embedded DTRs.
Here, the difference between the mean outcome had all clusters received DTR (1,1) and the mean outcome had all clusters received DTR (À1,À1)-i.e. E 1,1 ðY ij Þ À E À1,À1 ðY ij Þ-is given by 2ð 1 þ 2 Þ.
Estimation
We now present an estimator for the unknown coefficients ðb, gÞ. 
Notation
Let X i denote the m i Â p matrix ðX i1 , X i2 , . . . , X im i Þ T of
Estimator
Building on Nahum-Shani et al., 12 Orellana et al., 13 and Lu et al., 23 we obtain estimates of the coefficients (b, g) through solving an estimating equation.
In the estimator, the m i Â ðq þ pÞ matrix DðX i , a 1 , a 2 Þ is the derivative of lðX i , a 1 , a 2 ; b, gÞ with respect to ðb, gÞ; it can be thought of as the ''design matrix'' for DTR (a 1 , a 2 ). For example, using the model in equation (1) for ADEPT, the jth row of 2 ) is a working model for the covariance of Y i conditional on X i for DTR (a 1 , a 2 ), Cov a 1 ,a 2 ðY i jX i Þ. In practice, the matrix V i,a 1 ,a 2 is unknown and must be estimated prior to solving equation (3), see section 3.3.
The function IðA 1i , R i , A 2i , a 1 , a 2 Þ (abbreviated I i,a 1 ,a 2 ) is a cluster-level indicator function which identifies whether (equals 1) or not (equals 0) cluster i was assigned to a sequence of treatments that is consistent with DTR (a 1 , a 2 ). For example, in ADEPT, if A 1i ¼ 1, R i ¼ 0, and A 2i ¼ À1, then cluster i is consistent only with DTR (1,À1), whereas if A 1i ¼ 1, R i ¼ 1, then cluster i is consistent with both DTRs (1,1) and (1,À1).
The weights WðA 1i , A 2i , R i Þ (abbreviated W i ) are the known cluster-level inverse probability weights (IPW), Tables 1 and 2 for the known values of W i in ADEPT and the prototypical SMART.
We obtain estimates ðb,ĝÞ by solving for ðb, gÞ in
The estimates ðb,ĝÞ derived from solving equation (3) are consistent and asymptotically normally distributed assuming the mean model (e.g. equation (1) for ADEPT) is correctly specified. As in the generalized estimating equations literature, 37, 38 there is no requirement that the working model V i,a 1 ,a 2 be a correct model for Cov a 1 ,a 2 ðY i jX i Þ. See supplementary material for a sketch of the derivations.
Intuition for the weights
By design, in the observed data in a SMART, different clusters have different probabilities of being consistent with a specific DTR. For example, clusters assigned to cells A and B are consistent with DTR (1,1) (see Figure 1 and Table 1 ). However, clusters assigned to cell A had a 50% chance of being consistent with DTR (1,1), whereas clusters assigned to cell B had 25% chance of being consistent with DTR (1,1). Ignoring this known imbalance-i.e. using an unweighted average of observations in cells A and B to estimate the mean outcome had the entire population of clusters been assigned to DTR (1,1)-would cause the Cell A observations to have an unfairly larger influence on the estimator, leading to bias. The weights are designed to counteract this known imbalance and ensure that all clusters consistent with DTR (a 1 , a 2 ) are represented equally. For example, in ADEPT, clusters in cell A are weighted by 1/0.5 ¼ 2, whereas clusters in cell B are weighted by 1/0.25 ¼ 4.
Implementation
Typically, in clustered settings, our working model for Cov a 1 ,a 2 ðY i jX i Þ, V i,a 1 ,a 2 , is taken to be exchangeable and independent of X i , i.e.
Þ. Here ) is an m i Â m i exchangeable matrix (i.e. ½ExchðÞ ii ¼ 1 and ½ExchðÞ ij ¼ for i 6 ¼ j). Given this working model, the estimators ðb,ĝÞ can be obtained using the following steps:
Step 1: Solve equation (3) with V i,a 1 ,a 2 set to the identity matrix to obtain ðb 0 ,ĝ 0 ). For each embedded DTR (a 1 , a 2 ) obtain the residuals ij,ða 1 
Step 2: Estimate 2Ã a 1 ,a 2 and
Step 3: Solve equation (3) with
Þ to obtain ðb 1 ,ĝ 1 Þ.
Step 4: Repeat Steps 2 and 3 with ij,ða 1 ,a 2 Þ ðb 1 ,ĝ 1 Þ to obtain final estimates ðb,ĝÞ.
In simulations, we do not find appreciable performance gains by iterating Steps 2 and 3 more than twice. Steps 1-4 can be seen as extensions of standard GEE analysis. 37, 38 Also, some analysts may choose to specify a working correlation structure which is equal for all DTRs. In this case, one could take a simple average of the estimates in equation (4) across all regimens (a 1 , a 2 ). Lastly, it is well known that by replacing the known W i in each step above with estimated weights, statistical efficiency of the estimators may be improved.
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Standard error estimation
To estimate the variance of ðb,ĝÞ, we use the plug-in estimator, given by the ðq þ pÞ Â ðq þ pÞ matrix
ĝÞ
See supplementary materials for an adjustment to the standard errors for the case when weights are estimated.
Hypothesis testing
For any linear combination of ðb, gÞ, say c T ðb, gÞ where c is a (q þ p)-dimensional column vector, we use the
q to test the null hypothesis H 0 : c T ðb, gÞ ¼ 0. For example, in ADEPT, to test the difference in means had the entire population of clusters followed DTR (1,1) versus DTR (À1,.) (i.e. primary aim (iv) above) using the model in equation (1), we set c ¼ ð0, 2, 1, 0 p Þ T . In large samples, Z has a standard normal distribution under the null hypothesis. Hence, an level test is ''reject H 0 when jZj 4 z =2 ,'' where z =2 is the upper =2 quantile of a standard normal distribution.
Sample size formulae
For both ADEPT and the prototypical SMART, we develop sample size formulae for the total number of clusters N for comparing the mean patient-level outcome between two embedded DTRs beginning with different stage 1 treatments. Specifically, for ADEPT, formulae are developed for testing null hypotheses of the form H 0 : E 1,b 2 ðY ij Þ À E À1,: ðY ij Þ ¼ 0 for a fixed b 2 2 ðÀ1, 1Þ against alternate hypotheses of the form 
. The formulae are based on using equation (3) to estimate the coefficients b in marginal models of the form (1) or (2) as follows: (i) with or without a prespecified cluster-level covariate X i , (ii) known weights W i , and (iii) an exchangeable working covariance structure for V i,a 1 ,a 2 . In addition, formulae are based on large sample approximations and a constant cluster size m i ¼ m for all i. Extensions to the unequal cluster size case can be done as in Kerry and Bland 46 or by conservatively setting m equal to the minimum cluster size. They also rely on the following working population assumptions.
(1) Equal exchangeable covariance matrices across regimens: We assume the true marginal covariance matrices are equal for the two DTRs we are testing (e.g.
(2) Conditional covariance inequality: For a specific DTR, we assume non-responders do not vary from the marginal mean significantly more than responders. This assumption applies to different DTRs based on design, see below. A concern about this assumption should be raised only if the scientist, apriori, believed that, for a specific DTR, non-responders had significantly larger variances than responders or if the response rate was expected to be much larger than 0.5 (which is atypical for SMART designs). See Appendix 1 for details. (3) Correct marginal mean model: We assume that E a 1 ,a 2 ðY ij jX i Þ ¼ ðX i , a 1 , a 2 ; b, Þ for the pre-specified clusterlevel X i , where ðX i , a 1 , a 2 ; b, Þ is of the form (1) or (2) . When X i is not included in equations (1) or (2), this assumption is met trivially.
Each formula is a function of the cluster size m, the effect size , the outcome's ICC, , the probability of a cluster responding after receiving a particular initial treatment, p 1 ¼ PðR ¼ 1jA 1 ¼ 1Þ and p À1 ¼ PðR ¼ 1jA 1 ¼ À1Þ, and the standard normal quantiles z =2 and z , where is the size of our test and 1 À is the power. We first provide formulae for estimation without covariates followed by the case when a cluster-level covariate X i is used.
ADEPT sample size formula
For ADEPT, working assumption 2 is:
Also, for ADEPT, working assumption 1 can be relaxed to
. Under these assumptions, we obtain the sample size formula
Prototypical sample size formula
For prototypical SMART designs, working assumption 2 is: for both DTRs in our test, i.e.
Under these assumptions, we obtain the sample size formula
Note this formula is identical to the formula in Ghosh et al. 17 Also, note that we believe working assumptions 1-3 are implicit in their work.
The sample size formulae in formulas (5) and (6) are intuitive. The first two terms in both formulae are identical; these terms compose the formula for the sample size for the difference in means in a 2-arm randomized control trial (RCT) with cluster-level randomization. 3 The second term, in particular, is the expression for the variance inflation factor (VIF) arising from cluster-randomized trials. If ¼ 0 (i.e. VIF ¼ 1), there is no inflation due to cluster randomization because we have no correlation within clusters. As increases, each new observation within a cluster provides less unique information causing the VIF to increase. This, in turn, leads to an increase in sample size, N.
The third term, which is unique to SMARTs, is used to account for the fact that some clusters are re-randomized depending on response at the end of stage 1; hence, this last term is a function of the rate of response to first stage intervention. To understand this third term, it is useful to consider the following two extremes in the context of the prototypical SMART. If both response rates (p 1 , p À1 ) are 1, then there is no re-randomization and the design is analogous to a 2-arm cluster-randomized RCT (here, the third term is equal to 1). If, on the other hand, both response rates are 0, then all clusters are randomized twice; here, the third term is equal to 2. Note how the third term is different for ADEPT and the prototypical SMART due to the difference in randomization schemes. Also, the special case where response rates to initial treatments are equal (i.e. p 1 ¼ p À1 ) leads to a clustered version of the sample size formula in Oetting et al. 14 
Sample size formulae with a cluster-level covariate
. We obtain the following sample size formula for ADEPT
For the prototypical SMART, the sample size formula is
The use of a covariate leads to two changes in the sample size formulae. First, as expected, 16 depending on the strength of the correlation between X and Y (i.e. Cor 2 ðY, XÞ), the use of a covariate has the potential to reduce the minimum required sample size; this is because the use of covariates may improve the efficiency of our estimate of the coefficients b. Second, there is a reduction in sample size due to the reduction in correlation, Ã , which, by definition, is always less than .
Using the sample size formula for the ADEPT study
To exemplify how the formula can be utilized in practice, we calculate how large of a difference between DTRs (1,À1) and (À1,.) we can detect in ADEPT. This difference would help us understand if it is better to give REP þ EF þ IF to non-responding clinics initially, or to delay REP þ EF þ IF until a clinic is non-responsive to REP þ EF. In ADEPT, we expect the ICC of patient's MH-QOL to be ¼ 0:01 and the probability of responding when initially receiving REP þ EF to be p 1 ¼ 0:2. Using the true sample size of N ¼ 60, a common cluster size of m ¼ 10, and performing an ¼ 0.05 level test (z =2 ¼ 1:96), by rearranging formula (5), we conclude that at 80% power (z ¼ 0:84), we can detect an effect size of ¼ 0.282.
Simulations
Simulations were conducted to evaluate the developed formulae and understand their robustness to violations of the working assumptions. Specifically, we evaluate formulae under four scenarios: (1) satisfying all working assumptions, (2) violating working assumption 1, (3) violating working assumption 2, and (4) violating working assumption 3. For each scenario, we compare the nominal power of 0.9 with the estimated power (based on 1000 iterations). Here, we present results for ADEPT; results were similar for the prototypical SMART.
Details concerning the data generative model can be found in Appendix 2. Data were generated to mimic the ADEPT study. We considered different data generative scenarios with varied standardized effect sizes ( ¼ 0.2 (small), 0.5 (moderate)), cluster sizes (m ¼ 5, 10, 20), ICC ( or Ã ¼ 0.01 or 0.1), and, when there is a cluster-level covariate, the correlation between X and Y (Cor 2 ðY, XÞ 2 ½0:04, 0:4). We also considered different scenarios constituting violations of the working assumptions (details below). For each scenario, the sample size was selected based on the proposed formulae with nominal power (1 À ) ¼ 0.9 and Type-I error rate ¼ 0:05; 1000 data sets were generated for each scenario. Each data set was analyzed as in sections 3.3 and 3.4, using the marginal mean model in equation (1) . Table 3 describes simulation results for the sample size formula in formula (5). To violate assumption 1, we made the response variance under DTRð1, b 2 Þ 1.5 times the response variance under DTR ðÀ1, :Þ. We could have also violated this assumption by deviating from an exchangeable covariance structure; however, in clusterrandomized trials, it is rare to use another covariance structure. 47 To violate assumption 2, we made nonresponders have significantly larger variance than responders under DTR ð1, b 2 Þ.
As expected, when no assumptions are violated (column 5), our estimated power is close to our pre-specified power, 0.9. When assumption 1 is violated (column 6) or assumption 2 is violated (column 7), we see that our power does not reduce dramatically. Hence, we conclude that our sample size formula is robust to violations of working assumptions 1 and 2. Also, the Type-I error rate does not depend on working assumptions 1 or 2. Hence, under each of these scenarios, with the effect size set to 0, the Type-I error rate is close to the nominal rate of 0.05.
Because working assumption 3 will always be true when there are no covariates, we run a second simulation, this time with a cluster-level covariate, to evaluate the robustness of the sample size formula in formula (7) to a violation of this assumption. Specifically, to violate assumption 3, we deviate from the linear marginal mean in equation (1) by generating data with E a 1 ,a 2 
e. the linear marginal mean is misspecified outside of ½Àk, k). Here is chosen to maintain the same values of CorðY, XÞ. Setting k ¼ 2 indicates a small violation (column 7) and setting k ¼ 1 indicates a large violation (column 8). We still, however, analyze the data using the marginal mean model in equation (1) . The results are in Table 4 .
As expected, when no assumptions are violated (column 6), our estimated power is close to our pre-specified power, 0.9. Note the reduction in sample size caused by the addition of a covariate. Under a small violation (column 7), we see the power is not significantly reduced. Under a large violation (column 8), we see our power is lowest when X and Y are moderately correlated and the sample size is low. This is because when X and Y are weakly correlated, the overall influence of X is small, and hence misspecification of the relationship between X and Y will have little influence on our estimation and power. Also, once again, under these scenarios, with the effect size set to 0, the Type-I error rate is close to the nominal rate of 0.05. The proportion is significantly different from 0.9 at the 5% level. ICC: intra-cluster correlation.
Discussion and future work
This manuscript presents a regression estimator and sample size formulae for comparing embedded DTRs using data arising from a cluster-randomized SMART. Methods were motivated by the ADEPT SMART, a study designed to develop a DTR (at the level of community-based mental health clinics) to improve mental health outcomes for patients clustered within those sites. 11 Sample size formulae were derived for both ADEPT and for a more common type of SMART.
There are a number of directions for future research in the analysis of cluster-randomized SMARTs. First, relatively staightforward applications of the estimator in equation (3) with different link functions can be used to analyze, for example, binary, count, or zero-inflated outcomes.
Second, in practice, many cluster-randomized SMARTs will collect longitudinal (i.e. repeated measures) research outcomes at the patient-level. A natural next step is to combine the estimator presented here with methods for the analysis of longitudinal SMART outcomes 23 in order to accommodate two levels of clustering: repeated measures within patients within clusters.
Third, future work could also consider the use of variance components models, i.e. mixed effects or random effects models, 2, 48 which are now-standard in the analysis of randomized trials. Fourth, while this manuscript focuses on the analysis of primary aims in a SMART, in the DTR literature, there is much interest in the development and application of analysis methods designed to generate hypotheses about more individually tailored DTRs. [49] [50] [51] [52] [53] [54] [55] Much of this literature has focused on identifying optimal DTRs at the individual level. Such methods could be extended for the analysis of data arising from cluster-randomized SMARTs to develop optimal cluster-level DTRs.
There are also a number of interesting methodological issues related to the design of cluster-randomized SMARTs (with implications for analysis methods). First, the sample size formulae derived here were limited to cases where our data contain a single cluster-level covariate. Future work may provide extensions to data containing multiple covariates and individual-level covariates.
Second, in this manuscript, we focus on SMARTs that are useful for developing cluster-level DTRs where the initial and subsequent decisions are all at the cluster-level. However, there is currently much interest by educational scientists in SMARTs aimed at developing DTRs where sequences of intervention decisions are made at both the cluster and individual level. For example, we are currently involved in the conduct of a trial where the first stage intervention is at the level of classrooms with children with autism (such classrooms often include one to three children with autism), and the subsequent stages of intervention are at the level of the children themselves. 56 For ADEPT, we postulate a model of the form
Fitting the re-parameterized models will yield the exact same conclusions as fitting the marginal mean models in equations (1) and (2).
Prototypical design without covariates
For data arising from a prototypical SMART design, we derive the sample size formula for detecting a significant difference between mean outcomes from two treatment regimens, (b 1 , b 2 ) and (c 1 , c 2 ) . Because we are interested in comparing two regimes starting with a different initial treatment, without loss of generality, we let b 1 ¼ 1 and
We are interested in testing the hypothesis
Against the alternative
¼ Var a 1 ,a 2 ðY ij Þ, and is the standardized effect size. We make a series of assumptions to derive our sample size formulae. We highlight these assumptions throughout our derivation to illustrate their use in the calculation. Note that our sample size is developed for a fixed cluster size, m (extensions to the unequal cluster size case can be done as in Kerry et al. 46 ). Our test statistic used for the hypothesis test is
Here, 2 ða 1 , a 2 Þ is an estimate of the variance, 2 ða 1 , a 2 Þ ¼ Var( ffiffiffiffi N p ða 1 , a 2 Þ) which can be calculated using the matrix,AE^h, given in the supplementary material.
In large samples and under assumption 3 described in section 4, the distributions ofð1, b 2 Þ andðÀ1, c 2 Þ can be approximated by a normal distribution,
, c 2 ÞÞ ¼ 0 (the covariance is 0 due to the independence of estimators of marginal means with different initial treatments). Thus, Z approximately has a standard normal distribution under the null hypothesis.
Note that these calculations are exactly the same as those highlighted in section 3.5. Specifically, under the original parameterization, letting c ¼ ð0 14 for a hypothesis test of size , in order to obtain desired power of 1 À , we need to find N that satisfies
Everything in this formula can be explicitly found except 2 ð1, b 2 Þ and 2 ðÀ1, c 2 Þ. Hence, we now aim to derive upper bounds for these variables in order to write our sample size formula in terms of either known or easily elicited quantities.
Note that under the parameterization, for any DTR (a 1 , a 2 ), a 2 ) (e.g. the (3,3) element for DTR ðÀ1, 1Þ). We define the m x m matrix D a 1 ;a 2 :¼ Cov a 1 ;a 2 ðY i Þ. Also, the vector 1 m is defined as the m Â 1 vector of 1's. Lastly, as defined in section 4, p a 1 is the probability of responding given the cluster had received initial treatment a 1 .
After simplification, we find that J is a diagonal matrix with diagonal elements 
To go from line 1 to 2, we assume Robin's consistency assumption holds, i.e. that the cluster's observed outcomes equal the cluster's potential outcomes under the observed DTR. 57 Under this assumption, we are able to switch from E, which is an expected value over observed data, to E a 1 ,a 2 which is the expected value had the entire population received DTR (a 1 , a 2 ). 31, 32 For further simplification, we now make assumption 2. This assumption is equivalent to assuming, for a specific DTR (a 1 , a 2 ) (we drop the a 1 , a 2 from the subscripts for convenience) jð
R , R are the mean, variance, and ICC of responders had the whole population received DTR (a 1 , a 2 ), (i.e. R ¼ E a 1 ,a 2 ðY ij jR i ¼ 1Þ, 2 ðY ij jR i ¼ 1Þ), similarly defined for NR and nonresponders (i.e. conditional on R ¼ 0). Again, p a 1 is the probability of response, given initial treatment a 1 .
For DTR (a 1 , a 2 ), this condition is satisfied if the probability of response is less than or equal to 0.5 (which is typical for prototypical SMART designs), the non-responders of that regimen have a variance which is less than or equal to the variance of responders of the regimen, and both responders and non-responders have similar within cluster covariances.
Under assumption 2 and using our previous simplification, we can bound our expression for
We next utilize the fact that our working covariance matrix, V i,a 1 ,a 2 , is exchangeable. With some linear algebra, this assumption allows us to perform the following simplification 
where the numbering above the equalities and inequalities illustrates which assumption is being used.
Making assumption 1 (on marginal population variances and correlations) will lead to equality of expected conditional variances and correlations due to the simple relationship between the conditional and marginal variances and covariances highlighted above. Hence, we define
, A 1 ,R,A 2 are the cell means, variances, and ICCs since they correspond to each cell in Figure 1 . Under the specified means, variances, and ICCs in Table 5 , one can easily obtain the desired marginal (over R) means, variances, and ICCs under a specific DTR using the laws of total expectation and variation. For example, to obtain the marginal mean under DTR (1,1) Table 5 ), the cell means and variances were first chosen to give marginal means and variances which are both similar to results expected in ADEPT and produce effect sizes matching Table 3 . After obtaining the correct effect size, the cell ICCs were then chosen also to match values specified in Table 3 . To violate assumptions (row 2 and 3 of Table 5 ), the cell means, variances, and ICCs from row 1 were altered to create the correct violations.
With a cluster-level covariate
To generate data for Table 4 , we use a continuous cluster-level covariate. We generate data (X, A 1 , R, A 2 , Y), using the values in Table 6 and, for each of the N clusters, doing the following:
(1) Generate A 1 to be 1 or À1 with equal probability. (2) Generate R to be 1 with probability p A 1 and 0 otherwise. are the cell means, conditional cell variances, and conditional cell ICCs since they correspond to each cell in Figure 1 . Also, f k is the same piecewise function defined in section 5 (i.e. which is non-linear outside of ½Àk, k).
Under the specified conditional means, variances, and ICCs in Table 6 , one can again obtain the desired conditional (on X only) and marginal means, variances, and ICCs under a specific DTR using the laws of total expectation and variation. For example, to obtain the conditional variance under DTR (1,1), one would calculate The cell means, variances, and ICCs were chosen for the same reason as in the non-covariate case. The parameter, , was chosen to match the Cor(Y, X) values in Table 4 . 
